Telmisartan Market is Estimated to Witness High Growth Owing to Opportunities in Hypertension Treatment

 
Telmisartan Market

Telmisartan is an antihypertensive drug used for the treatment of essential hypertension. It acts by selectively blocking the angiotensin II receptors, thereby lowering blood pressure. Telmisartan has shown better control of blood pressure with fewer side effects compared to other anti-hypertensive drugs, and can be used as monotherapy or in combination therapy.

The global telmisartan market is estimated to be valued at US$ 4109.53 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The growing prevalence of hypertension across the world presents a major opportunity for the telmisartan market. As per the World Health Organization, hypertension affects over 1.13 billion people globally, with two-thirds of hypertension cases reported in developing nations. High blood pressure is a primary risk factor for cardiovascular and kidney diseases. The increasing awareness regarding management of hypertension and benefits of controlling blood pressure are encouraging more people to opt for treatment. Telmisartan has emerged as an effective therapy for hypertension due to its high efficacy and tolerability. The expanding patient pool of hypertension worldwide will likely drive significant demand for telmisartan over the forecast period.

Porter’s Analysis
Threat of new entrants: The telmisartan market is consolidated with the presence of large players operating globally, making it difficult for new players to enter the market. However, it has moderate profit potential due to patent expirations of major drugs.

Bargaining power of buyers: The bargaining power of buyers is moderate as telmisartan has few substitutes available for the treatment of hypertension. However, buyers can negotiate on price by increasing volume purchases.

Bargaining power of suppliers: The bargaining power of suppliers is low due to the availability of substitutable raw materials supplied by various vendors globally. Supplier switching costs are also low.

Threat of new substitutes: The threat of new substitutes is moderate as there are a few drug alternatives and substitutes available for telmisartan in the management of hypertension.

Competitive rivalry: The competitive rivalry is high owing to the presence of global and domestic players offering generic versions after major drugs lose exclusivity. Players compete on price and product differentiation.

SWOT Analysis
Strengths: High usage in hypertension therapy, long patent protection expired, availability of low-cost generics.
Weaknesses: High R&D costs, stringent regulations for approval.
Opportunities: Growth in emerging markets, focus on fixed dose combinations.
Threats: Patent expiries of blockbuster drugs, regulatory hurdles.

Key Takeaways
The Global Telmisartan Market Demand is expected to witness high growth over the forecast period owing to the increasing prevalence of hypertension worldwide. The global Telmisartan Market is estimated to be valued at US$ 4109.53 Bn in 2023 and is expected to exhibit a CAGR of 5.2% over the forecast period 2024 to 2031.

The Asia Pacific region currently dominates the market and is expected to grow at the fastest rate due to the large patient pool and rising healthcare expenditures in countries like China and India.

Key players operating in the telmisartan market are Global Self Storage Inc., U-Haul International Inc. (Amerco), Urban Self Storage Inc., Life Storage Inc., Amsdell Cos./Compass Self Storage, CubeSmart LP, All Storage, National Storage Affiliates Trust, National Storage REIT, Safestore Holdings PLC, (Great Value Storage) World Class Capital Group LLC, Simply Self Storage Management LLC, SmartStop Asset Management LLC, StorageMart, Metro Storage LLC, Prime Storage Group, and W. P. Carey Inc. Regional analysis focuses on increasing production of generics in Asia and strategy of manufacturers to strengthen presence.

For more details on the report, Read-https://www.ukwebwire.com/telmisartan-market-growth-market-size-share-analysis/

Comments

Post a Comment

Popular posts from this blog

Precast Concrete Market Is Estimated To Witness High Growth Owing To Increasing Demand for Sustainable Construction Practices

Image
Precast Concrete Market Market Overview: The Precast Concrete Market is witnessing significant growth due to the increasing demand for sustainable construction practices. Precast concrete products are prefabricated in controlled factory conditions, offering several advantages such as improved quality control, reduced construction time, and increased durability. These products are widely used in residential, commercial, and infrastructure projects due to their ability to enhance construction efficiency and productivity. With the growing need for energy-efficient and environmentally friendly buildings, the demand for precast concrete products is expected to rise. Market Key Trends: One key trend in the Precast Concrete Market is the adoption of advanced technology in manufacturing processes. The use of computer-aided design (CAD) and building information modeling (BIM) is enabling manufacturers to produce complex and customized precast concrete products with high precision. Additional
Read more

Relapsed Or Refractory Diffuse Large B Cell Lymphoma Market Growth driven by increased adoption of targeted therapies

Image
Relapsed Or Refractory Diffuse Large B Cell Lymphoma Market Market Overview: Relapsed Or Refractory Diffuse Large B Cell Lymphoma (R/R DLBCL) is an aggressive fast-growing type of non-Hodgkin's lymphoma (NHL) cancer that generally affects immune system cells called B cells. DLBCL can occur at any age but is most common in older adults. Novel targeted therapies like chimeric antigen receptor (CAR) T-cell therapies, bispecific antibodies and antibody-drug conjugates are revolutionizing the treatment of R/R DLBCL. These advanced therapies are offering new hope to patients by increasing survival rates. Market key trends: One of the key trends in the R/R DLBCL market is the increasing adoption of CAR T-cell therapies. CAR T-cell therapy is an innovative new approach to treating R/R DLBCL through the use of genetically engineered T-cells. Drugs like Kymriah and Yescarta have proven highly effective in treating certain patients with relapsed or refractory forms of large B-cell lymphoma.
Read more

Poultry Market is Expected to be Flourished by Growing Demand for Protein-Rich Food

Image
Poultry Market The poultry market comprises farming of domesticated birds such as chickens, ducks, turkeys, and geese, primarily for their meat and eggs. Poultry meat is one of the most consumed meats globally owing to its high protein content. Chicken is the most commonly produced meat worldwide, with over 95 million tons produced annually. Poultry farming provides affordable animal protein to consumers while generating income and employment for farmers and allied industries. The global poultry industry includes large integrated production facilities, small commercial farms, and backyard flock operations. Technological advancements have increased efficiency in breeding, hatching, feeding, housing, and disease control. The global poultry market is estimated to be valued at US$ 15.88 billion in 2023 and is expected to exhibit a CAGR of 5.6% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market Dynamics: One of the key driv
Read more